The disclosure also provides methods of screening for and diagnosing prostate cancer and methods of choosing a therapeutic for prostate cancer based on a lower KDM5D expression having a more aggressive clinical course of prostate cancer in human patients.CHRISTOPHER SWEENEY...
Conclusions: Screening for prostate cancer may reduce prostate cancer mortality, but to the cost of over-detection and over-treatment.doi:10.5430/jst.v2n2p23Sandblom, GabrielSciedu PressJournal of Solid Tumors
More intensive screening is not always optimal. Impact: Guidelines for screening men at increased PCa risk should consider the mechanism inducing the increased risk. While the benefit of screening may be greater in men with increased risks, more intensive screening is not always appropriate. 展开 ...
The goal of prostate cancer screening is to detect only those men at risk for death from the disease at an early curable phase. The ambiguous natural history of this most common malignancy in men, being latent with questionable life-threatening potential in a large number of cases on the one...
For patients presenting with prostate imaging reporting and data system (PI-RADS) 3/4 findings on magnetic resonance imaging (MRI) examinations, the standard recommendation typically involves undergoing a biopsy for pathological assessment to ascertain the nature of the lesion. This course of action, ...
Diagnosis and Prognosis of Prostate Cancer byRosalyn Carson-DeWitt, MD Main Page|Risk Factors|Reducing Your Risk|Screening|Symptoms| Diagnosis |Treatment Overview|Chemotherapy|Radiation Therapy|Surgical Procedures|Hormonal Therapy|Other Treatments|Lifestyle Changes|Living With Prostate Cancer|Talking to Your ...
Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann. Intern. Med. 157, 120–134 (2012). PubMed Google Scholar Fleshner, K., Carlsson, S. V. & Roobol, M. J. The effect of the USPSTF PSA screening recommendation on prostate cancer incidence ...
Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent Bolla et al., "EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent," European Urology,... N Mottet,RCNVD Bergh,E Briers,... - 《European Urology》 被引...
Screening for prostate cancer. N Engl J Med. 2011;365:2013–9. Article CAS Google Scholar Bohnen AM, Groeneveld FP, Bosch JLHR. Serum prostate-specific antigen as a predictor of prostate volume in the community: the Krimpen study. Eur Urol. 2007;51:1645–53. Article Google Scholar ...
Recently, the incidence of prostate cancer in Japan has been markedly increased because of the aggressive use of serum PSA at urological clinics and/or screening. However, the limitations of serum PSA in diagnosis of prostate cancer are also well known. While the volume adjusted PSA, PSA isoform...